Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Preferred Stock Liabilities (2017 - 2021)

Historic Preferred Stock Liabilities for Surgery Partners (SGRY) over the last 5 years, with Q1 2021 value amounting to $439.7 million.

  • Surgery Partners' Preferred Stock Liabilities rose 870.21% to $439.7 million in Q1 2021 from the same period last year, while for Mar 2021 it was $439.7 million, marking a year-over-year increase of 870.21%. This contributed to the annual value of $434.5 million for FY2020, which is 1000.0% up from last year.
  • According to the latest figures from Q1 2021, Surgery Partners' Preferred Stock Liabilities is $439.7 million, which was up 870.21% from $434.5 million recorded in Q4 2020.
  • Surgery Partners' Preferred Stock Liabilities' 5-year high stood at $439.7 million during Q1 2021, with a 5-year trough of $330.8 million in Q3 2017.
  • In the last 5 years, Surgery Partners' Preferred Stock Liabilities had a median value of $381.2 million in 2019 and averaged $382.9 million.
  • As far as peak fluctuations go, Surgery Partners' Preferred Stock Liabilities soared by 1000.0% in 2020, and later skyrocketed by 870.21% in 2021.
  • Quarter analysis of 5 years shows Surgery Partners' Preferred Stock Liabilities stood at $330.8 million in 2017, then grew by 8.61% to $359.3 million in 2018, then increased by 9.94% to $395.0 million in 2019, then increased by 10.0% to $434.5 million in 2020, then increased by 1.2% to $439.7 million in 2021.
  • Its Preferred Stock Liabilities was $439.7 million in Q1 2021, compared to $434.5 million in Q4 2020 and $424.2 million in Q3 2020.